Xenetic Biosciences Inc. Company Profile
NASDAQ: XBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Xenetic Biosciences at a glance
Xenetic Biosciences Inc. (NASDAQ: XBIO) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Framingham, MA. Xenetic Biosciences is led by Mr. James F. Parslow and employs about 2 people. At a market capitalization of $5.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001534525, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Xenetic Biosciences do?
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance. The company's product pipeline includes XBIO-015 for the treatment of pancreatic carcinoma and solid tumors; XBIO-020 for the treatment of solid tumors; and ErepoXen, which uses PolyXen platform technology for the treatment of anemia in chronic kidney disease (CKD) patients. It has a sublicensing agreement with Takeda Pharmaceutical Co. Ltd, as well as various research, development, license and supply agreements with Serum Institute of India, PJSC Pharmsynthez, and SynBio, LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Xenetic Biosciences Inc.
- Ticker
- NASDAQ: XBIO
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. James F. Parslow
- Employees
- 2
- Headquarters
- 945 Concord Street, Framingham, MA, United States
- Phone
- 781 778 7720
- Website
- xeneticbio.com
- Market cap
- $4.97M
- SEC CIK
- 0001534525
Companies similar to Xenetic Biosciences
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DRMADermata Therapeutics Inc. | 1.02 | -4.67% | $5.05M | vs XBIO |
| ENLVEnlivex Ltd. | 0.254 | -8.30% | $5.06M | vs XBIO |
| XTLBXTL Biopharmaceuticals Ltd. ADR | 1.98 | 0.00% | $4.87M | vs XBIO |
| RDHLRedhill Biopharma Ltd. ADR | 0.539 | -6.75% | $4.79M | vs XBIO |
| PPCBPropanc Biopharma Inc. | 0.4857 | +3.12% | $4.77M | vs XBIO |
| PULMPulmatrix Inc. | 1.46 | -4.39% | $5.33M | vs XBIO |
| NCNANuCana plc ADR | 1.10 | -2.22% | $4.58M | vs XBIO |
| LNAILunai Bioworks Inc. | 1.23 | +9.82% | $5.58M | vs XBIO |